866-997-4948(US-Canada Toll Free)

United States Specific Cancer Immunotherapy Drugs Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Cancer

No. of Pages : 101 Pages

This report studies sales (consumption) of Specific Cancer Immunotherapy Drugs  in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Amgen
Roche
Bristol Myers Squibb
Dendreon (Valeant)
Novartis
Seattle Genetics
Hangzhou Jinjiang Group

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Tablet
Injection
Split by applications, this report focuses on sales, market share and growth rate of  Specific Cancer Immunotherapy Drugs  in each application, can be divided into
Leukemia Treatment
Colorectal Cancer Treatment
Other Cancer Treatment

Table of Contents

1 Specific Cancer Immunotherapy Drugs  Overview
1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs
1.2 Classification of Specific Cancer Immunotherapy Drugs
1.2.1 Tablet
1.2.2 Injection
1.3 Application of Specific Cancer Immunotherapy Drugs
1.3.1 Leukemia Treatment
1.3.2 Colorectal Cancer Treatment
1.3.3 Other Cancer Treatment
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Specific Cancer Immunotherapy Drugs  (2011-2021)
1.4.1 United States Specific Cancer Immunotherapy Drugs  Sales and Growth Rate (2011-2021)
1.4.2 United States Specific Cancer Immunotherapy Drugs  Revenue and Growth Rate (2011-2021)

2 United States Specific Cancer Immunotherapy Drugs  Competition by Manufacturers
2.1 United States Specific Cancer Immunotherapy Drugs  Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Specific Cancer Immunotherapy Drugs  Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Specific Cancer Immunotherapy Drugs  Average Price by Manufactures (2015 and 2016)
2.4 Specific Cancer Immunotherapy Drugs  Market Competitive Situation and Trends
2.4.1 Specific Cancer Immunotherapy Drugs  Market Concentration Rate
2.4.2 Specific Cancer Immunotherapy Drugs  Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Specific Cancer Immunotherapy Drugs  Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Specific Cancer Immunotherapy Drugs  Sales and Market Share by States (2011-2016)
3.2 United States Specific Cancer Immunotherapy Drugs  Revenue and Market Share by States (2011-2016)
3.3 United States Specific Cancer Immunotherapy Drugs  Price by States (2011-2016)

4 United States Specific Cancer Immunotherapy Drugs  Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Specific Cancer Immunotherapy Drugs  Sales and Market Share by Type (2011-2016)
4.2 United States Specific Cancer Immunotherapy Drugs  Revenue and Market Share by Type (2011-2016)
4.3 United States Specific Cancer Immunotherapy Drugs  Price by Type (2011-2016)
4.4 United States Specific Cancer Immunotherapy Drugs  Sales Growth Rate by Type (2011-2016)

5 United States Specific Cancer Immunotherapy Drugs  Sales (Volume) by Application (2011-2016)
5.1 United States Specific Cancer Immunotherapy Drugs  Sales and Market Share by Application (2011-2016)
5.2 United States Specific Cancer Immunotherapy Drugs  Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Specific Cancer Immunotherapy Drugs  Manufacturers Profiles/Analysis
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.1.2.1 Tablet
6.1.2.2 Injection
6.1.3 Amgen Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Roche
6.2.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.2.2.1 Tablet
6.2.2.2 Injection
6.2.3 Roche Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Bristol Myers Squibb
6.3.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.3.2.1 Tablet
6.3.2.2 Injection
6.3.3 Bristol Myers Squibb Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Dendreon (Valeant)
6.4.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.4.2.1 Tablet
6.4.2.2 Injection
6.4.3 Dendreon (Valeant) Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.5.2.1 Tablet
6.5.2.2 Injection
6.5.3 Novartis Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 Seattle Genetics
6.6.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.6.2.1 Tablet
6.6.2.2 Injection
6.6.3 Seattle Genetics Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 Hangzhou Jinjiang Group
6.7.2 Specific Cancer Immunotherapy Drugs  Product Type, Application and Specification
6.7.2.1 Tablet
6.7.2.2 Injection
6.7.3 Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview

7 Specific Cancer Immunotherapy Drugs  Manufacturing Cost Analysis
7.1 Specific Cancer Immunotherapy Drugs  Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Specific Cancer Immunotherapy Drugs  Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs  Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Specific Cancer Immunotherapy Drugs  Market Forecast (2016-2021)
11.1 United States Specific Cancer Immunotherapy Drugs  Sales, Revenue Forecast (2016-2021)
11.2 United States Specific Cancer Immunotherapy Drugs  Sales Forecast by Type (2016-2021)
11.3 United States Specific Cancer Immunotherapy Drugs  Sales Forecast by Application (2016-2021)
11.4 Specific Cancer Immunotherapy Drugs  Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

Figure Picture of Specific Cancer Immunotherapy Drugs
Table Classification of Specific Cancer Immunotherapy Drugs
Figure United States Sales Market Share of Specific Cancer Immunotherapy Drugs  by Type in 2015
Figure Tablet Picture
Figure Injection Picture
Table Application of Specific Cancer Immunotherapy Drugs
Figure United States Sales Market Share of Specific Cancer Immunotherapy Drugs  by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure United States Specific Cancer Immunotherapy Drugs  Sales and Growth Rate (2011-2021)
Figure United States Specific Cancer Immunotherapy Drugs  Revenue and Growth Rate (2011-2021)
Table United States Specific Cancer Immunotherapy Drugs  Sales of Key Manufacturers (2015 and 2016)
Table United States Specific Cancer Immunotherapy Drugs  Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Specific Cancer Immunotherapy Drugs  Sales Share by Manufacturers
Figure 2016 Specific Cancer Immunotherapy Drugs  Sales Share by Manufacturers
Table United States Specific Cancer Immunotherapy Drugs  Revenue by Manufacturers (2015 and 2016)
Table United States Specific Cancer Immunotherapy Drugs  Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Specific Cancer Immunotherapy Drugs  Revenue Share by Manufacturers
Table 2016 United States Specific Cancer Immunotherapy Drugs  Revenue Share by Manufacturers
Table United States Market Specific Cancer Immunotherapy Drugs  Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Specific Cancer Immunotherapy Drugs  Average Price of Key Manufacturers in 2015
Figure Specific Cancer Immunotherapy Drugs  Market Share of Top 3 Manufacturers
Figure Specific Cancer Immunotherapy Drugs  Market Share of Top 5 Manufacturers
Table United States Specific Cancer Immunotherapy Drugs  Sales by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Sales Share by States (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs  Sales Market Share by States in 2015
Table United States Specific Cancer Immunotherapy Drugs  Revenue and Market Share by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Revenue Share by States (2011-2016)
Figure Revenue Market Share of Specific Cancer Immunotherapy Drugs  by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Price by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Sales by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Sales Share by Type (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs  Sales Market Share by Type in 2015
Table United States Specific Cancer Immunotherapy Drugs  Revenue and Market Share by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Specific Cancer Immunotherapy Drugs  by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Price by Type (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs  Sales Growth Rate by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Sales by Application (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs  Sales Market Share by Application (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs  Sales Market Share by Application in 2015
Table United States Specific Cancer Immunotherapy Drugs  Sales Growth Rate by Application (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs  Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information List
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Hangzhou Jinjiang Group Basic Information List
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs  Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs  Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Specific Cancer Immunotherapy Drugs  Industrial Chain Analysis
Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs  Major Manufacturers in 2015
Table Major Buyers of Specific Cancer Immunotherapy Drugs
Table Distributors/Traders List
Figure United States Specific Cancer Immunotherapy Drugs  Production and Growth Rate Forecast (2016-2021)
Figure United States Specific Cancer Immunotherapy Drugs  Revenue and Growth Rate Forecast (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs  Production Forecast by Type (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs  Consumption Forecast by Application (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs  Sales Forecast by States (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs  Sales Share Forecast by States (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *